Marvelon

Desogestrel/Ethinylestradiol, the active ingredient in Marvelon, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus and endometrial lining.

GNH USA supplies Marvelon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Marvelon, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent pregnancy.

Pregnancy prevention: Provides reliable contraception for women of childbearing potential.

Oral contraceptives may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea: mild stomach upset, often transient. - Breast tenderness: discomfort or swelling of the breasts. - Headache: mild to moderate intensity. - Weight gain: slight increase in body weight. - Mood changes: irritability or mood swings. - Breakthrough bleeding: spotting between periods.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Arterial thrombosis: clot formation in arteries, potentially causing stroke or heart attack. - Hypertension: significant increase in blood pressure. - Liver disorders: jaundice or hepatic dysfunction. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Visual disturbances: sudden vision loss or blurred vision.

Before prescribing Marvelon, clinicians should evaluate several safety considerations to minimize risk.

Smoking: Avoid use in women over 35 who smoke, due to increased cardiovascular risk. Cardiovascular disease: Contraindicated in patients with a history of myocardial infarction, stroke, or uncontrolled hypertension. Thromboembolic history: Not recommended for individuals with prior deep‑vein thrombosis or pulmonary embolism. Liver disease: Use with caution in patients with active liver disease or impaired hepatic function. Migraine with aura: Contraindicated in women experiencing migraine headaches accompanied by visual or sensory aura. Store at ambient temperature: Keep below 25 °C, in the original packaging, protected from moisture and light.

Marvelon can interact with other medicines, altering its effectiveness or increasing adverse effects.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampicin, carbamazepine, phenytoin): reduce contraceptive efficacy. - Certain antiretrovirals (e.g., efavirenz, nevirapine): may lower hormone levels. - St. John’s wort: potentiate hepatic metabolism, decreasing effectiveness.

Moderate Interactions (Monitor Closely): - Antifungals (e.g., ketoconazole, itraconazole): may increase hormone concentrations. - Selective serotonin reuptake inhibitors (SSRIs): occasional alteration of hormone levels. - Antihypertensives (e.g., beta‑blockers, ACE inhibitors): may require dose adjustment. - Diuretics: potential for electrolyte imbalance. - Antiepileptics (e.g., valproate): may affect hormone metabolism.